TWiV 1010: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses the CDC HIV surveillance report, FDA voted in favor of approving the Abrysvo vaccine, canine olfactory detection of SARS-CoV-2-infected humans, safety of the BNT162b2 COVID-19 vaccine in children aged 5 to 17 years, and statement on the antigen composition of COVID-19 vaccines.
Subscribe (free):\xa0Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0email
Become a\xa0patron\xa0of\xa0TWiV!
Links for this episode- HIV\xa0surveillance report (CDC)
- FDA voted in favor of approving\xa0Abrysvo vaccine\xa0(Pfizer)
- Canine olfactory detection\xa0of SARS-CoV-2-infected humans (Annals of Epidemiology)
- Safety of the\xa0BNT162b2 COVID-19 vaccine\xa0in children (JAMA)
- Statement on the antigen composition of\xa0COVID-19 vaccines\xa0(WHO)
- Contribute to our\xa0FIMRC fundraiser at PWB
- Letters read\xa0on TWiV 1010
- Timestamps by\xa0Jolene. Thanks!
Intro music is by\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv